| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 742 | 2.439 | 14.350 | 24.640 | 23.451 | 20.453 | 28.017 | 29.568 | 34.184 | 39.515 |
| Total Income - EUR | 742 | 2.439 | 14.350 | 24.641 | 23.451 | 20.453 | 28.017 | 31.531 | 34.184 | 39.515 |
| Total Expenses - EUR | 34 | 158 | 148 | 110 | 158 | 633 | 1.446 | 4.157 | 8.080 | 8.139 |
| Gross Profit/Loss - EUR | 709 | 2.282 | 14.202 | 24.531 | 23.294 | 19.821 | 26.571 | 27.374 | 26.105 | 31.375 |
| Net Profit/Loss - EUR | 687 | 2.208 | 13.771 | 23.792 | 22.632 | 19.256 | 25.892 | 26.639 | 22.649 | 27.250 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Msg Betamed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 121 | 120 | 118 | 116 | 113 | 939 | 603 | 9.622 | 7.958 | 3.172 |
| Current Assets | 1.555 | 3.694 | 17.298 | 28.218 | 16.847 | 22.127 | 7.438 | 2.974 | 8.332 | 9.271 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 849 | 0 | 0 | 0 |
| Receivables | 0 | 295 | 1.398 | 1.622 | 0 | 0 | -516 | 59 | 0 | 0 |
| Cash | 1.555 | 3.399 | 15.899 | 26.596 | 16.847 | 22.127 | 7.105 | 2.914 | 8.332 | 9.271 |
| Shareholders Funds | 1.485 | 3.573 | 17.284 | 23.835 | 16.798 | 22.928 | 5.860 | 6.236 | 15.322 | 27.299 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 191 | 240 | 131 | 4.499 | 163 | 137 | 2.181 | 6.359 | 968 | -14.856 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Msg Betamed Srl